Traws Pharma Inc Sustainability Reports
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for respiratory viral diseases and oncology. The company's pipeline includes oral small molecule antiviral agents targeting influenza, H5N1 bird flu, and COVID-19.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2024 to 2024
Company Profile
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for respiratory viral diseases and oncology. The company's pipeline includes oral small molecule antiviral agents targeting influenza, H5N1 bird flu, and COVID-19.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years